Rituximab treatment for patients with Wegener's granulomatosis

Not Applicable

• Conditions: Wegener' s granulomatosis

• Registration Number: JPRN-UMIN000007076
• Lead Sponsor: Kawasaki Medical School

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

The case who is disqualified by the physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
complete remission at 12 months

Secondary Outcome Measures

Name	Time	Method
adverse events, BVAS/WG